The Food and Drug Administration (FDA) submitted a report to Congress on the state of the CBD marketplace on Wednesday, and the document outlines studies the agency has performed on the contents and quality of cannabis-derived products that it has tested over the past six years. The report, which... Read more
The Food and Drug Administration (FDA) submitted a report to Congress on the state of the CBD marketplace on Wednesday, and the document outlines studies the agency has performed on the contents and quality of cannabis-derived products that it has tested over the past six years. The report, which... Read more
The Food and Drug Administration (FDA) submitted a report to Congress on the state of the CBD marketplace on Wednesday, and the document outlines studies the agency has performed on the contents and quality of cannabis-derived products that it has tested over the past six years. The report, which... Read more
EverQuote Inc: COVID-19 Helps Fuel 333% Year-Over-Year Gains
COVID-19 Makes EverQuote Stock a Stronger Play EverQuote Inc (NASDAQ:EVER) was already an amazing tech stock with huge potential heading into 2020. EverQuote stock soared a whopping 725% in 2019 and investors were increasingly optimistic about its near-term and long-term outlooks. Then COVID-19 happened, which has made EVER stock an even... Read more
Will This $4 Stock Change the Future of Electric Cars?
ElectraMeccanica Vehicles Corp Is an EV Stock You Likely Haven’t Considered Whether you like electric vehicles (EV) or not, it’s hard to deny that the industry has become an investor favorite. It wasn’t that long ago that Tesla Inc (NASDAQ:TSLA) stock was trading at around $200.00 apiece. Now it’s... Read more
Don’t Sleep on Possibly the Best Stock Opportunity of 2020
Coronavirus Stocks Could Soar Due to COVID-19 Vaccine It seems simple: if you’re able to cure a global pandemic, it would only make sense that you’d be rewarded financially (not to mention have literally millions of people thanking you for getting us out of the nightmare). As you’d expect,... Read more
A class-action lawsuit over packaging mislabeling filed in a Calgary court is taking aim at some of the Canadian cannabis market’s biggest names. Tilray, Aurora Cannabis, Aleafia Health, Hexo Corp., Cronos Group, Organigram Holdings, MediPharm Labs Corp. and their various subsidiaries and brands are all named as defendants in... Read more
A class-action lawsuit over packaging mislabeling filed in a Calgary court is taking aim at some of the Canadian cannabis market’s biggest names. Tilray, Aurora Cannabis, Aleafia Health, Hexo Corp., Cronos Group, Organigram Holdings, MediPharm Labs Corp. and their various subsidiaries and brands are all named as defendants in... Read more
A class-action lawsuit over packaging mislabeling filed in a Calgary court is taking aim at some of the Canadian cannabis market’s biggest names. Tilray, Aurora Cannabis, Aleafia Health, Hexo Corp., Cronos Group, Organigram Holdings, MediPharm Labs Corp. and their various subsidiaries and brands are all named as defendants in... Read more
A class-action lawsuit over packaging mislabeling filed in a Calgary court is taking aim at some of the Canadian cannabis market’s biggest names. Tilray, Aurora Cannabis, Aleafia Health, Hexo Corp., Cronos Group, Organigram Holdings, MediPharm Labs Corp. and their various subsidiaries and brands are all named as defendants in... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )